E. Giroux-Leprieur

Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study

C. Morélot-Panzini, N. Roche, P. Brillet, 2023, European Respiratory Journal.

First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study

O. Molinier, M. Denis, D. Moro-Sibilot, 2021, Clinical Cancer Research.